SYDNEY, AUSTRALIA / ACCESSWIRE / August 30, 2021 / Rapid Nutrition PLC(Euronext Growth: ALRPD)(OTCQB: RPNRF), a naturopathic company specializing in sports nutrition, diet management and life science products with extensive global sales, is pleased to announce the addition of David Hunter to its advisory board. Dr. Hunter is Professor of Medicine at the University of Sydney, where he serves as the Florance and Cope Chair of Rheumatology and Chair of the Institute of Bone and Joint Research.
Ranked as the world’s leading expert on osteoarthritis on expertscape.com, Dr. Hunter studies the effects of obesity on joint pain, which makes him an ideal addition to the wellness company’s board of directors. Dr. Hunter is also a personnel specialist at the Royal North Shore Hospital.
“Our scientific team has just gained incredible knowledge, experience and relevance with the addition of world-renowned professor and osteoarthritis expert Dr. David Hunter,” said Simon St. Ledger, CEO of Rapid Nutrition. “We are very excited to welcome him to our board of directors and look forward to sharing his expertise and insights with consumers around the world.”
“I am honored to be in touch with Rapid Nutrition, a company dedicated to developing high quality, science-based nutrition,” said Dr. Hunter who specializes in studying arthritis and the effects of obesity and healthy eating.
Dr. Hunter is also a member of the Editorial Board of Arthritis and Rheumatology, Osteoarthritis and Cartilage, Arthritis Care and Research, and a member of the Examination Board for the American College of Rheumatology Scientific Sessions, EULAR and OARSI. He has over 500 peer-reviewed publications in international journals and is the co-author of several books. In 2019 he received the OARSI Clinical Researcher Award as well as the Vice-Chancellor’s Award for Research Excellence and the Distinguished Professorial Achievement Award from the University of Sydney.
The story goes on
The native New Zealander and Australian citizen earned his Bachelor of Medicine, Bachelor of Surgery and Master of Sports Medicine from the University of New South Wales. He completed a scholarship in rheumatology from the Royal Australian College of Physicians and earned a Masters of Medical Science (Clinical Epidemiology) from the University of Newcastle. He also hosts a “Joint Action” podcast available on iTunes.
About fast nutrition
Dedicated to developing and distributing world-class, science-based health and wellness brands around the world, Rapid Nutrition shares a plethora of award-winning products with consumers passionate about innovations “made by nature, refined by science” . Rapid Nutrition’s world-class scientific team combines the experience of its management team to keep both the company and consumers updated on the latest industry trends and developments, while working with industry leaders worldwide to provide effective nutritional supplements and solutions. Rapid Nutrition aims to be the supplier of choice worldwide by offering premium brands with the highest quality ingredients for maximum results.
More information is available at http://rnplc.com.
Investor Relations Contact:
ir@rnplc.com
Disclaimer of liability
This press release contains forward-looking statements under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and / or otherwise that involve risks, uncertainties and assumptions that could cause the actual results and experiences of Rapid Nutrition PLCs to differ materially the expected results and expectations that are expressed in these forward-looking statements. Rapid Nutrition PLC has in some instances forward-looking statements through the use of the words “expects,” “believes,” “hopes,” “estimates,” “looks”, “expects,” “plans,” “intends”, “goal.” “,” Potential, “” may, “” suggest “and similar expressions. Rapid Nutrition PLC assumes no obligation to publicly release the results of revisions to such forward-looking statements that are made to reflect events or circumstances after the date of this press release or to reflect the occurrence of unforeseen events, unless otherwise required by applicable law or regulation .
This media information constitutes neither an offer to sell nor an invitation to submit an offer to buy securities. This information does not constitute an offer prospectus within the meaning of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 on the prospectus which is to be published when securities are offered to the public or when securities are admitted to trading on a regulated market and to repeal Directive 2003/71 or a listing prospectus within the meaning of the listing rules of the Euronext Exchange or OTC Markets. The press release complies with the International Reporting Standard: Rule 12g3-2 (b) of the Securities Exchange Act (‘Rule 12g3-2 (b)’) allows non-US companies whose securities are primarily listed on a qualifying foreign exchange exchange to be US investors The same information that is made publicly available in English is the same information that is made publicly available in their home countries as an alternative to SEC reporting under Exchange Act Rule 12g3-2 (b).
SOURCE: Rapid Nutrition PLC
View source version on accesswire.com:
https://www.accesswire.com/662117/University-of-Sydney-Professor-and-Rheumatology-Researcher-David-Hunter-Joins-Rapid-Nutrition-Scientific-Advisory-Board
